HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Abstract Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Maeder, M. Articles by Rickli, H. Search for Related Content PubMed PubMed Citation Articles by Maeder, M. Articles by Rickli, H.

Contrast nephropathy: Review focusing on prevention

Micha Maeder, MD^*,*, Maja Klein, MD, Thomas Fehr, MD and Hans Rickli, MD^*

^* Division of Cardiology, Department of Internal Medicine
Division of General Internal Medicine, Department of Internal Medicine, Kantonsspital St. Gallen, St. Gallen, Switzerland
Transplantation Biology Research Center, Massachusetts General Hospital, Boston, Massachusetts, USA

View larger version (36K): [in a new window]   Figure 1 Suggested algorithm for therapeutic recommendations to prevent contrast nephropathy. *Angiotensin-converting enzyme inhibitors, angiotensin receptor blocking agents, non-steroidal anti-inflammatory drugs, diuretics, aminoglycosides, calcineurin inhibitors; chronic renal insufficiency, diabetes, multiple myeloma, congestive heart failure, or age >70 years. b.i.d. = twice a day; IV = intravenous.